4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.
暂无分享,去创建一个
P. Hoskin | T. Illidge | Paul D. Smith | M. Robinson | I. Syndikus | A. Jack | E. Gallop‐Evans | B. Popova | A. Kirkwood | C. Brammer | P. Diez | S. Coltart | K. Madhavan